Search Results 671-680 of 14778 for anti-TNF drugs

  1. Ertugliflozin And Sitagliptin (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  2. Tetracycline (Topical Application Route) Description and Brand Names - Mayo Clinic

    Tetracyclines belong to the family of medicines called antibiotics. The topical ointment forms are used to treat infections of the skin. Meclocycline cream and ...

  3. Tretinoin (Topical Route) Proper Use - Mayo Clinic

    Proper Use. Drug information provided by: Merative, Micromedex®. Use this medicine only as directed by your doctor. Do not use more of it, ...

  4. Natalizumab-Sztn (Intravenous Route) Description and Brand Names - Mayo Clinic

    Natalizumab-sztn injection is also used to treat moderate to severe Crohn's disease (CD) when other medicines or treatments did not work well.

  5. Dextromethorphan And Quinidine (Oral Route) Precautions - Mayo Clinic

    Check with your doctor first before taking any other medicines. This medicine will add to the effects of alcohol and other CNS depressants (medicines that make ...

  6. Peripheral nerve tumors - Diagnosis and treatment - Mayo Clinic

    Learn about these growths that form in or near nerves connecting to the spinal cord. Surgery is the most common treatment.

  7. ... TREATMENT,6554 230000003,HC WOUND VAC TX 1ST ... DRUG,171 260000009,HC IV PUSH EA ADD SEQ NEW ... ANTI-XA,157 301000889,HC RIVAROXABAN ANTI-XA,157 ...

  8. Butalbital And Aspirin Combination (Oral Route) Before Using - Mayo Clinic

    Allergies. Tell your doctor if you have ever had any unusual or allergic reaction to medicines in this group or any other medicines. Also tell your health care ...

  9. Antivenin (Latrodectus Mactans) (Injection Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  10. Non-Hodgkin's Lymphoma Clinical Trials - Mayo Clinic Research

    Rituximab, an anti-CD20 chimeric antibody, was approved by the United States Food and Drug Administration in 1998 for the treatment of patients with relapsed ...